Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.
#351 most reported symptom for this vaccine
Thrombocytopenic purpura has been reported 62 times in association with Hib (Pedvaxhib) vaccination in VAERS. This represents 0.1% of all 60,298 reports for this vaccine.
Among these reports, 0 mentioned death (0.00%) and 50 involved hospitalization (80.6%).
Thrombocytopenic purpura is the #351 most frequently reported symptom for Hib (Pedvaxhib) out of 2013 total symptoms.
Disclaimer: VAERS reports describe events that occurred after vaccination but do not establish that the vaccine caused the event. Many reported symptoms may be coincidental or related to underlying conditions.
Seeing 62 reports of Thrombocytopenic purpura after Hib (Pedvaxhib) vaccination may seem alarming, but context is critical.
The mortality rate among these reports is very low at 0.00%, suggesting most cases are non-fatal.
This data comes from the Vaccine Adverse Event Reporting System (VAERS), jointly managed by CDC and FDA.